Juno Therapeutics Recent News
Short Interest Surges In Illumina And Vertex Pharmaceuticals
Short Sellers Dump Amgen And Baxalta
Juno Therapeutics Lower, To Acquire AbVitro For $78 Million In Cash And Nearly 1.30 Million Shares
Vetr Crowd Sees Juno Therapeutics As A Five-Star Stock
3 Biotech Stocks See Growing Short Interest
3 Biotech Stocks With Rising Short Interest
3 Industries In A Bubble That Aren't Technology
Short Sellers Come Back To Biotech Stocks